ӳ��ý

Publications

Natural Language Processing to Adjudicate Heart Failure Hospitalizations in Global Clinical Trials.

Marti-Castellote PM, Reeder C, Claggett BL, et al. Natural Language Processing to Adjudicate Heart Failure Hospitalizations in Global Clinical Trials. Circulation. Heart failure. 2024. doi:10.1161/CIRCHEARTFAILURE.124.012514

Functional genomics of human skeletal development and the patterning of height heritability.

Richard D, Muthuirulan P, Young M, et al. Functional genomics of human skeletal development and the patterning of height heritability. Cell. 2024. doi:10.1016/j.cell.2024.10.040

Association of polygenic liabilities for schizophrenia and bipolar disorder with educational attainment and cognitive aging.

Wu CS, Hsu CL, Lin MC, et al. Association of polygenic liabilities for schizophrenia and bipolar disorder with educational attainment and cognitive aging. Translational psychiatry. 2024;14(1):472. doi:10.1038/s41398-024-03182-6

KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes.

Assatova B, Willim R, Trevisani C, et al. KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes. Clinical cancer research : an official journal of the American Association for Cancer Research. 2024;30(11):2514-2530. doi:10.1158/1078-0432.CCR-23-3504

Genetic Analysis of Obstructive Sleep Apnea and Its Relationship with Severe COVID-19.

Strausz S, Agafonova E, Tiullinen V, et al. Genetic Analysis of Obstructive Sleep Apnea and Its Relationship with Severe COVID-19. Annals of the American Thoracic Society. 2024;21(6):961-970. doi:10.1513/AnnalsATS.202303-215OC

The Irreversible FGFR Inhibitor KIN-3248 Overcomes FGFR2 Kinase Domain Mutations.

Balasooriya ER, Wu Q, Ellis H, et al. The Irreversible FGFR Inhibitor KIN-3248 Overcomes FGFR2 Kinase Domain Mutations. Clinical cancer research : an official journal of the American Association for Cancer Research. 2024;30(10):2181-2192. doi:10.1158/1078-0432.CCR-23-3588

DNA damage response defects in hematologic malignancies: mechanistic insights and therapeutic strategies.

Kwok M, Agathanggelou A, Stankovic T. DNA damage response defects in hematologic malignancies: mechanistic insights and therapeutic strategies. Blood. 2024;143(21):2123-2144. doi:10.1182/blood.2023019963

Dual role of signaling pathways in myeloma requires cell type-specific targeting of ligand-receptor interactions.

Hernandez-Lopez P, Vijaykumar T, Anand P, et al. Dual role of signaling pathways in myeloma requires cell type-specific targeting of ligand-receptor interactions. Blood advances. 2024;8(12):3173-3185. doi:10.1182/bloodadvances.2023011463

Soluble Human Lectins at the Host-Microbe Interface.

Peiffer AL, Dugan AE, Kiessling LL. Soluble Human Lectins at the Host-Microbe Interface. Annual review of biochemistry. 2024;93(1):565-601. doi:10.1146/annurev-biochem-062917-012322

Proteomics, Human Environmental Exposure, and Cardiometabolic Risk.

Perry AS, Zhang K, Murthy VL, et al. Proteomics, Human Environmental Exposure, and Cardiometabolic Risk. Circulation research. 2024;135(1):138-154. doi:10.1161/CIRCRESAHA.124.324559